Psyence Biomedical Ltd is a CA-based company operating in Biotechnology industry. The company is headquartered in Toronto, Ontario and currently employs 12 full-time employees. The company went IPO on 2021-12-10. Psyence Biomedical Ltd is a multi-asset, vertically integrated biopharmaceutical company specializing in psychedelic-based therapeutics. The firm is focused on developing nature-derived (non-synthetic) psilocybin-based psychedelic medicine. The company is dedicated to addressing unmet mental health needs, particularly in palliative care. Its ongoing Phase IIb psilocybin clinical trial in Australia focuses on adjustment disorder in patients diagnosed with cancer.
PBM stock price ended at $2.81 on jeudi, after dropping 5.07%
On the latest trading day Feb 12, 2026, the stock price of PBM fell by 5.07%, dropping from $2.87 to $2.81. During the session, the stock saw a volatility of 10.26%, with prices oscillating between a daily low of $2.73 and a high of $3.01. On the latest trading day, the trading volume for PBM rose by 19.9K shares, despite the declining prices. This uptick in volume may signal heightened risk in the near term. In total, 82.5K shares were traded, with a market value of approximately $5.2M.
Signaux Techniques de PBM
Résumé des Signaux Techniques
Acheter des signaux 3
Signaux neutres 0
Signaux de vente 4
Strong Sell
Sell
Neutral
Buy
Strong Buy
PBM présente actuellement 3 signaux d'achat et 4 signaux de vente. L'action est en Tendance baissière depuis 12:00 AM, avec une variation totale du prix de -11.64% pendant cette période. En général, les indicateurs techniques indiquent une tendance Sell à moyen terme.
Signaux haussiers/baissiers pour PBM
Nous analysons les indicateurs clés comme les moyennes mobiles, le RSI, le MACD et le volume de transactions pour générer des signaux haussiers et baissiers pour PBM, vous aidant à prendre des décisions d'investissement éclairées.